GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » Net Margin %

Sunho Biologics (HKSE:02898) Net Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Sunho Biologics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sunho Biologics's Net Income for the six months ended in Jun. 2024 was HK$-38.84 Mil. Sunho Biologics's Revenue for the six months ended in Jun. 2024 was HK$0.00 Mil. Therefore, Sunho Biologics's net margin for the quarter that ended in Jun. 2024 was 0.00%.

The historical rank and industry rank for Sunho Biologics's Net Margin % or its related term are showing as below:

HKSE:02898' s Net Margin % Range Over the Past 10 Years
Min: -63660.53   Med: -33331.97   Max: -3003.41
Current: -63660.53

HKSE:02898's Net Margin % is ranked worse than
97.09% of 995 companies
in the Biotechnology industry
Industry Median: -114.45 vs HKSE:02898: -63660.53

Sunho Biologics Net Margin % Historical Data

The historical data trend for Sunho Biologics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunho Biologics Net Margin % Chart

Sunho Biologics Annual Data
Trend Dec22 Dec23 Dec24
Net Margin %
-3,003.41 -63,660.53 -

Sunho Biologics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % - - -34,162.28 - -

Competitive Comparison of Sunho Biologics's Net Margin %

For the Biotechnology subindustry, Sunho Biologics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunho Biologics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunho Biologics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sunho Biologics's Net Margin % falls into.


;
;

Sunho Biologics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sunho Biologics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-145.146/0.228
=-63,660.53 %

Sunho Biologics's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-38.838/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunho Biologics  (HKSE:02898) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Sunho Biologics Net Margin % Related Terms

Thank you for viewing the detailed overview of Sunho Biologics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunho Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » Net Margin %
Comparable Companies
HKSE:02185 HKSE:06628 HKSE:02126 HKSE:09939 HKSE:02511 HKSE:00690 HKSE:01244 HKSE:02257 HKSE:02197 HKSE:06622 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 198 Peninsula Middle Road, Dipu Street, Room 302, Building 3, Anji County, Zhejiang Province, Huzhou, CHN
Website
http://www.sunho-bio.com.cn
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
Executives
Sunho Fortune Investments Limited 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Zhang Feng 2201 Interest of corporation controlled by you
Sunho Wisdom Investments Limited 2101 Beneficial owner

Sunho Biologics Headlines

No Headlines